Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk.

Patients in the LOWER glucose group showed a nonsignificant trend to higher hematocrit values and to a higher prevalence of nephro- and neuropathy than individuals in the remaining groups (Table 1 ).

also in 5,406 other papers